Edition:
United States

American Bio Medica Corp (ABMC.PK)

ABMC.PK on OTC Markets Group

0.10USD
--
Change (% chg)

-- (--)
Prev Close
$0.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,128
52-wk High
$0.17
52-wk Low
$0.05

Summary

Name Age Since Current Position

Melissa Waterhouse

44 2014 Chief Executive Officer, Principal Accounting and Financial Officer

Jean Neff

72 2014 Corporate Secretary, Independent Director

Chaim Davis

37 2017 Director

Diane Generous

55 2014 Director

Biographies

Name Description

Melissa Waterhouse

Ms. Melissa A. Waterhouse is Chief Executive Officer, Principal Accounting and Financial Officer of American Bio Medica Corporation. Since that time she has held various management positions in Investor Relations, Marketing, Public Relations and Corporate Compliance. She served as our Corporate Secretary from September 2003 until her interim appointment as Chief Executive Officer and Chief Financial Officer in October 2013. In June 2014, Ms. Waterhouse was appointed as Chief Executive Officer, Principal Financial Officer and was appointed to the Board of Directors to fill the vacancy left by the Company’s former Chief Executive Officer.

Jean Neff

Ms. Jean Neff is Treasurer, Secretary, Independent Director of American Bio Medica Corporation. until her retirement in early 2014, she was the Sr. Vice President Mid-Atlantic Region of Solstas Lab Partners. She served as the Sr. Vice President of New Business Development of the Occupational Testing Services division of Laboratory Corporation of America, from 1991 until 2007. She received her B.S. in Biology from Mercer University in 1964. Ms. Neff provides decades of experience in administration, sales and management making her well qualified as a member of the Board.

Chaim Davis

Mr. Chaim Davis is Director of the Company. Since July 2005, Mr. Davis has been the Managing Member of Revach Group, LLC, the general partner of Revach Fund L.P. (“Revach”), a sector-specific life science fund focusing on micro to mid cap companies, which he founded in 2005. He has also served as a consultant to other hedge funds including Gem Partners, KOM Capital Management and Maot Group. From 2010 to 2014, he served as a director and a member of the audit and compensation committees of AtheroNova Inc. (OTCBQ: AHRO), and from 2001 to 2004, he served as a healthcare analyst at The Garnet Group. Mr. Davis received his B.A. from Columbia University. Since April 2013, Mr. Davis has also served on the Board of Directors of Entera Bio, a clinical stage biopharmaceutical company. There are no material arrangements, including compensation arrangements, between Mr. Davis and the Company other than customary compensation to board members.

Diane Generous

Ms. Diane J. Generous is Director of the Company. Ms. Generous is an attorney with over 25 years in strategic fundraising, development and advocacy communications. She received her JD from George Washington University and her BA in Economics from Duke University. Since January 2005, she has been a principal of Generous Associates, a consulting firm that provides political and non-profit strategies and fundraising services.

Basic Compensation

Name Fiscal Year Total

Melissa Waterhouse

154,317

Jean Neff

--

Chaim Davis

--

Diane Generous

--
As Of  30 Dec 2014

Options Compensation